BriaCell Therapeutics Corp. ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announces that on January 24, 2025 (the ...
The patent application No. 17/309,952 entitled “An A3 adenosine receptor ligand for use for achieving a fat loss effect”, has been accepted by the US Patent Office, will be issued on February 2 nd and ...
What makes Horizon unique when it comes to business lending? Our Commercial Banking Advisors are dedicated to providing comprehensive support throughout the entire loan process.... Describe your ...